82008-81-9

Basic information

• Product Name: (S)-methyl 2-((2S,3R)-3-acetamido-2-hydroxy-4-phenylbutanamido)-4-methylpentanoate
• Synonyms: (S)-methyl 2-((2S,3R)-3-acetamido-2-hydroxy-4-phenylbutanamido)-4-methylpentanoate
• CAS NO: 82008-81-9
• Molecular Weight: 364.442
• Mol File: 82008-81-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-methyl 2-((2S,3R)-3-acetamido-2-hydroxy-4-phenylbutanamido)-4-methylpentanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-methyl 2-((2S,3R)-3-acetamido-2-hydroxy-4-phenylbutanamido)-4-methylpentanoate(82008-81-9)
• EPA Substance Registry System: (S)-methyl 2-((2S,3R)-3-acetamido-2-hydroxy-4-phenylbutanamido)-4-methylpentanoate(82008-81-9)

Safety Data

• Hazardous Substances Data: 82008-81-9(Hazardous Substances Data)

Upstream product

• 58970-76-6 bestatin 
• 108-24-7 acetic anhydride 
• 65322-89-6 methyl (2S)-2-(((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl)amino)-4-methylpentanoate 

Downstream Products

• 1459703-80-0 (S)-methyl 2-((2S,3R)-3-acetamido-4-(4-bromophenyl)-2-hydroxybutanamido)-4-methylpentanoate 

Relevant articles and documents

Treatment of Pulmonary Hypertension with Leukotriene Inhibitors

Pulmonary arterial hypertension (PAH) can be prevented in persons susceptible to the diseases and PAH patients can be treated by administering an effective dose of a leukotriene inhibitor. Suitable inhibitors include leukotriene A4 hydrolase (LTA4H) inhibitors, leukotriene B4 receptor (BLT1/BLT2) antagonists, 5-lipoxygenase (5-LO) inhibitors, and 5-lipoxgygenase activating protein (FLAP) inhibitors.